Press releases

Efficacy of NMN! Potential to contribute to the maintenance of pets’ health

Mirailab Bioscience Inc. (HQ: Chuo-ku, Tokyo, CEO: Megumi Tanaka) was pleased to report the results of the joint research with Professor Toru Kimura of Yamaguchi University, Joint Faculty of Veterinary Medicine (Yamaguchi City, Yamaguchi Prefecture, President: Yukio Tanizawa) at the 21st Congress of the Federation of Asian Veterinary Associations. At this conference, we studied the effects on dogs caused by the administration of nicotinamide mononucleotide (NMN) and reported the findings we obtained, which suggest that NMN administration may also contribute to the maintenance of pets’ health.

Click here for the press release.